Charles Schwab Trust CO Abb Vie Inc. Transaction History

Charles Schwab Trust CO

$1.14 Billion
Q3 2024

A detailed history of Charles Schwab Trust CO transactions in Abb Vie Inc. stock. As of the latest transaction made, Charles Schwab Trust CO holds 21,315 shares of ABBV stock, worth $3.74 Million. This represents 0.37% of its overall portfolio holdings.

Number of Shares

21,315

Previous 21,415 0.47%

Holding current value

$3.74 Million

Previous $3.67 Million 14.59%

% of portfolio

0.37%

Previous 0.34%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 09, 2024	SELL	$163.84 - $199.33 $16,384 - $19,933	-100 Reduced 0.47%	21,315 $4.21 Million
Q2 2024 Jul 17, 2024	BUY	$154.79 - $180.76 $128,475 - $150,030	830 Added 4.03%	21,415 $3.67 Million
Q1 2024 Apr 12, 2024	SELL	$159.82 - $182.1 $720,948 - $821,453	-4,511 Reduced 17.97%	20,585 $3.75 Million
Q4 2023 Jan 09, 2024	BUY	$137.6 - $154.97 $124,390 - $140,092	904 Added 3.74%	25,096 $3.89 Million
Q3 2023 Oct 19, 2023	BUY	$133.59 - $154.65 $644,037 - $745,567	4,821 Added 24.89%	24,192 $3.61 Million
Q2 2023 Jul 24, 2023	SELL	$132.51 - $164.9 $40,283 - $50,129	-304 Reduced 1.55%	19,371 $2.61 Million
Q1 2023 Apr 10, 2023	BUY	$144.61 - $166.54 $225,013 - $259,136	1,556 Added 8.59%	19,675 $3.14 Million
Q4 2022 Jan 26, 2023	BUY	$138.31 - $165.87 $368,872 - $442,375	2,667 Added 17.26%	18,119 $0
Q3 2022 Oct 18, 2022	BUY	$134.21 - $153.93 $34,089 - $39,098	254 Added 1.67%	15,452 $2.07 Million
Q2 2022 Jul 22, 2022	SELL	$137.62 - $174.96 $23,395 - $29,743	-170 Reduced 1.11%	15,198 $2.33 Million
Q1 2022 Apr 14, 2022	BUY	$131.98 - $163.75 $78,660 - $97,595	596 Added 4.03%	15,368 $2.49 Million
Q4 2021 Jan 14, 2022	SELL	$107.43 - $135.93 $2,685 - $3,398	-25 Reduced 0.17%	14,772 $2 Million
Q3 2021 Oct 08, 2021	BUY	$106.4 - $120.78 $15,534 - $17,633	146 Added 1.0%	14,797 $1.6 Million
Q2 2021 Aug 04, 2021	SELL	$105.21 - $117.21 $23,987 - $26,723	-228 Reduced 1.53%	14,651 $1.65 Million
Q1 2021 Apr 14, 2021	BUY	$102.3 - $112.62 $21,380 - $23,537	209 Added 1.42%	14,879 $1.62 Million
Q3 2020 Oct 30, 2020	BUY	$85.91 - $100.83 $19,759 - $23,190	230 Added 1.59%	14,670 $1.29 Million
Q2 2020 Jul 28, 2020	BUY	$73.37 - $98.18 $490,698 - $656,627	6,688 Added 86.27%	14,440 $1.42 Million
Q1 2020 Apr 09, 2020	BUY	$64.5 - $97.79 $149,962 - $227,361	2,325 Added 42.84%	7,752 $591,000
Q3 2019 Nov 15, 2019	BUY	$62.98 - $75.72 $341,792 - $410,932	5,427 New	5,427 $397,000

Others Institutions Holding ABBV

# of Institutions

3,852

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $310B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Trust CO with notifications on news.

Account

Charles Schwab Trust CO Abb Vie Inc. Transaction History